#Coronavirus Disease #Research References (by AMEDEO, June 29 ’24)

  1. LIU X, Zheng M, Zhang H, Feng B, et al
    Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-CoV-2 PLpro.
    Antiviral Res. 2024 Jun 22:105944. doi: 10.1016/j.antiviral.2024.105944.
    PubMed         Abstract available
  2. POTTER JA, Aitken A, Yang L, Hill J, et al
    HEX17(Neumifil): an intranasal respiratory biotherapeutic with broad-acting antiviral activity.
    Antiviral Res. 2024 Jun 22:105945. doi: 10.1016/j.antiviral.2024.105945.
    PubMed         Abstract available
  3. BALIGA-GIL A, Soszynska-Jozwiak M, Ruszkowska A, Szczesniak I, et al
    Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication.
    Antiviral Res. 2024 Jun 24:105946. doi: 10.1016/j.antiviral.2024.105946.
    PubMed         Abstract available


    BMJ
  4. LIMB M
    RCP president steps down “with immediate effect” after physician associates row.
    BMJ. 2024;385:q1383.
    PubMed        
  5. O’DOWD A
    RCGP calls for immediate freeze on recruitment of physician associates.
    BMJ. 2024;385:q1376.
    PubMed        
  6. LIMB M
    Covid-19: Study sheds light on how some people avoid the disease.
    BMJ. 2024;385:q1382.
    PubMed        
  7. HARGRAVE KL
    Long covid: I’d rather have a well researched and well informed doctor than “become my own physician”.
    BMJ. 2024;385:q1398.
    PubMed        
  8. RIMMER A
    How can I prepare for a general election?
    BMJ. 2024;385:q1371.
    PubMed        
  9. IACOBUCCI G
    Doctors are under attack from all sides, BMA chair tells annual meeting.
    BMJ. 2024;385:q1402.
    PubMed        
  10. DYER C
    Consultant tells court that fear of reprisal from management stopped him reporting Letby to police.
    BMJ. 2024;385:q1395.
    PubMed        
  11. DOWNS J, Baker S, Carnegie A
    Eating disorders: meeting the need for a data driven and coproduced response to pandemic disruption.
    BMJ. 2024;385:q1403.
    PubMed        
  12. MAHASE E, Rimmer A
    Doctors call for late rota penalties and for “consultant” to be protected title.
    BMJ. 2024;385:q1416.
    PubMed        
  13. IACOBUCCI G
    Manifesto health pledges from main parties are “unfunded commitments,” says IFS.
    BMJ. 2024;385:q1409.
    PubMed        
  14. EBIKEME C
    How Paris is preparing for the health threats of the Olympic Games.
    BMJ. 2024;385:q1263.
    PubMed        
  15. PATERLINI M
    Italy: Giving regions more power over healthcare will worsen inequalities, say critics.
    BMJ. 2024;385:q1415.
    PubMed        
  16. OLIVER D
    David Oliver: Will a Labour government rescue adult social care?
    BMJ. 2024;385:q1386.
    PubMed        
  17. COWPER A
    Unpicking the general election manifestos on health and care.
    BMJ. 2024;385:q1358.
    PubMed        
  18. HAM C
    The next government should support staff to improve care and increase investment.
    BMJ. 2024;385:q1423.
    PubMed        
  19. RICKENBACH M
    Reframing the “heartsink” feeling can help doctors find a resolution.
    BMJ. 2024;385:q1427.
    PubMed        

  20. Seven days in medicine: 19-25 June 2024.
    BMJ. 2024;385:q1399.
    PubMed        
  21. BUSE K, McKee M
    What next for UK development assistance under the next government?
    BMJ. 2024;385:q1392.
    PubMed        


    Clin Infect Dis
  22. SISE ME, Santos JR, Goldman JD, Tuttle KR, et al
    Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.
    Clin Infect Dis. 2024 Jun 24:ciae333. doi: 10.1093.
    PubMed         Abstract available
  23. ZENG G, Zhou Y
    Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Jun 26:ciae342. doi: 10.1093.
    PubMed        
  24. FUSCO D, Malenica I, Gunthard HF, Gupta SK, et al
    Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison from Two Large, Open-Label Studies.
    Clin Infect Dis. 2024 Jun 26:ciae336. doi: 10.1093.
    PubMed         Abstract available
  25. CHONG C, Wee LE, Jin X, Zhang M, et al
    Risks of SARS-CoV-2 JN.1 infection and COVID-19 associated emergency-department (ED) visits/hospitalizations following updated boosters and prior infection: a population-based cohort study.
    Clin Infect Dis. 2024 Jun 26:ciae339. doi: 10.1093.
    PubMed         Abstract available

  26. Rapid Guidelines to Address the Changing COVID-19 Pandemic.
    Clin Infect Dis. 2024;78:e81-e82.
    PubMed        


    Emerg Infect Dis
  27. OGATA T, Tanaka H, Kon A, Sakaibori N, et al
    Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2-Dominant Period, Japan.
    Emerg Infect Dis. 2024;30:1430-1433.
    PubMed         Abstract available
  28. BARAK MEM, Wu S, Luria G, Schnyder LP, et al
    Engaging Communities in Emerging Infectious Disease Mitigation to Improve Public Health and Safety.
    Emerg Infect Dis. 2024;30:1390-1397.
    PubMed         Abstract available
  29. IBA A, Hosozawa M, Hori M, Muto Y, et al
    Prevalence of and Risk Factors for Post-COVID-19 Condition during Omicron BA.5-Dominant Wave, Japan.
    Emerg Infect Dis. 2024;30:1380-1389.
    PubMed         Abstract available
  30. FESS LJ, Fell A, O’Toole S, D’Heilly P, et al
    COVID-19 Death Determination Methods, Minnesota, USA, 2020-2022(1).
    Emerg Infect Dis. 2024;30:1352-1360.
    PubMed         Abstract available
  31. KIIZA D, Semanda JN, Kawere BB, Ajore C, et al
    Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda-Lessons Learned and Recommendations for Future Pandemics.
    Emerg Infect Dis. 2024;30:1326-1334.
    PubMed         Abstract available


    Int J Infect Dis
  32. CHOI YJ, Kim HN, Lee J, Nham E, et al
    Erythema nodosum as an unusual skin manifestation of long COVID: A case report.
    Int J Infect Dis. 2024 Jun 25:107152. doi: 10.1016/j.ijid.2024.107152.
    PubMed         Abstract available
  33. HASEGAWA J, Sekizawa A, Tanaka H, Katsuragi S, et al
    Infection route associated with invasive group A streptococcal toxic shock syndrome in maternal deaths: Nationwide analysis of maternal mortalities in Japan.
    Int J Infect Dis. 2024 Jun 25:107154. doi: 10.1016/j.ijid.2024.107154.
    PubMed         Abstract available
  34. WAN EYF, Wang B, Lee AL, Zhou J, et al
    Comparative Effectiveness and Safety of BNT162b2 and CoronaVac in Hong Kong: A Target Trial Emulation.
    Int J Infect Dis. 2024 Jun 21:107149. doi: 10.1016/j.ijid.2024.107149.
    PubMed         Abstract available
  35. JEDLICKA P
    Furst et al. fail to address crucial biases other than the Healthy vaccinee effect.
    Int J Infect Dis. 2024 Jun 20:107143. doi: 10.1016/j.ijid.2024.107143.
    PubMed        
  36. SMID M, Tucek V, Madar R, Tachezy R, et al
    No evidence of a “healthy vaccinee effect” in COVID-19 vaccination data from the Czech Republic.
    Int J Infect Dis. 2024 Jun 19:107144. doi: 10.1016/j.ijid.2024.107144.
    PubMed        


    Intensive Care Med
  37. APPIAH JA, Barth A, McGloughlin S, Cecconi M, et al
    Global impact: WHO and ESICM collaboration in launching the COVID-19 skills preparation course.
    Intensive Care Med. 2024 Jun 25. doi: 10.1007/s00134-024-07469.
    PubMed        


    J Infect
  38. CHAKA A, Pan D, Irshad M, Piranie H, et al
    Inclusion of racial and ethnic groups in clinical trials for COVID-19 and post-acute COVID-19 syndrome: an analysis of studies registered on ClinicalTrials.gov.
    J Infect. 2024 Jun 20:106207. doi: 10.1016/j.jinf.2024.106207.
    PubMed        
  39. GONG X, Peng L, Wang F, Liu J, et al
    Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants.
    J Infect. 2024;89:106208.
    PubMed         Abstract available
  40. PEREZ-GARCIA C, Sempere J, de Miguel S, Hita S, et al
    Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023).
    J Infect. 2024;89:106204.
    PubMed         Abstract available


    J Med Virol
  41. GALLEGO-GARCIA P, Estevez-Gomez N, De Chiara L, Alvarino P, et al
    Dispersal history of SARS-CoV-2 in Galicia, Spain.
    J Med Virol. 2024;96:e29773.
    PubMed         Abstract available
  42. MALLICK A, Sukla S, De A, Biswas S, et al
    Evidences support that dengue virus can impart broad-spectrum immunity against betacoronaviruses in dengue endemic regions.
    J Med Virol. 2024;96:e29771.
    PubMed         Abstract available
  43. XIAO M, Banu A, Jia Y, Chang M, et al
    Circulation pattern and genetic variation of rhinovirus infection among hospitalized children on Hainan Island, before and after the dynamic zero-COVID policy, from 2021 to 2023.
    J Med Virol. 2024;96:e29755.
    PubMed         Abstract available


    J Virol
  44. PECHOUS RD, Malaviarachchi PA, Banerjee SK, Byrum SD, et al
    An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy.
    J Virol. 2024 Jun 28:e0079424. doi: 10.1128/jvi.00794.
    PubMed         Abstract available
  45. ZHAO J, Huang Y, Liukang C, Yang R, et al
    Dissecting infectious bronchitis virus-induced host shutoff at the translation level.
    J Virol. 2024 Jun 28:e0083024. doi: 10.1128/jvi.00830.
    PubMed         Abstract available


    JAMA
  46. WEN X, Yan J, Zhu Z
    Apixaban to Prevent Recurrence After Cryptogenic Stroke.
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.6848.
    PubMed        


    Lancet
  47. SCHRECKER T
    Canada’s reckoning?
    Lancet. 2024;403:2688.
    PubMed        


    Lancet Infect Dis
  48. BUERANO CC, Morita K
    Single dose of Dengvaxia vaccine: is it a cause for alarm?
    Lancet Infect Dis. 2024;24:670-671.
    PubMed        
  49. DUNSMUIR H
    Managing loss during the COVID-9 pandemic.
    Lancet Infect Dis. 2024;24:683.
    PubMed        
  50. GEERS D, Gommers L, Tan NH, Bogers S, et al
    Profiling the SARS-CoV-2-specific T-cell response.
    Lancet Infect Dis. 2024 Jun 20:S1473-3099(24)00377.
    PubMed        


    Life Sci
  51. RAHEEM MA, Rahim MA, Gul I, Reyad-Ul-Ferdous M, et al
    COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations.
    Life Sci. 2024 Jun 24:122861. doi: 10.1016/j.lfs.2024.122861.
    PubMed         Abstract available


    N Engl J Med
  52. CHEHADE M, Dellon ES, Spergel JM, Collins MH, et al
    Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.
    N Engl J Med. 2024;390:2239-2251.
    PubMed         Abstract available


    Nature
  53. MILKMAN KL, Ellis SF, Gromet DM, Jung Y, et al
    Megastudy shows that reminders boost vaccination but adding free rides does not.
    Nature. 2024 Jun 26. doi: 10.1038/s41586-024-07591.
    PubMed         Abstract available


    Science
  54. WADMAN M
    Plans for U.S. bat lab spark outbreak fears.
    Science. 2024;384:1392-1393.
    PubMed         Abstract available
  55. LAXMINARAYAN R, Gleason A, Sheen J, Saad-Roy CM, et al
    Unlock the potential of vaccines in food-producing animals.
    Science. 2024;384:1409-1411.
    PubMed         Abstract available

Published by

Giuseppe Michieli

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.